Compare TXG & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | MIR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | 2019 | N/A |
| Metric | TXG | MIR |
|---|---|---|
| Price | $34.76 | $18.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | $20.25 | ★ $27.25 |
| AVG Volume (30 Days) | 3.1M | ★ 3.8M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $245,893,000.00 | N/A |
| Revenue This Year | N/A | $23.95 |
| Revenue Next Year | $7.33 | $7.32 |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | ★ 68.06 | N/A |
| 52 Week Low | $10.51 | $15.58 |
| 52 Week High | $35.65 | $30.28 |
| Indicator | TXG | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 70.12 | 56.97 |
| Support Level | $16.11 | $16.49 |
| Resistance Level | $35.65 | $18.68 |
| Average True Range (ATR) | 2.41 | 0.87 |
| MACD | 0.21 | 0.16 |
| Stochastic Oscillator | 88.10 | 86.64 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.